S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
MarketBeat Week in Review – 9/18 - 9/22
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
Auto workers still have room to expand their strike against car makers. But they also face risks
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
MarketBeat Week in Review – 9/18 - 9/22
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
Auto workers still have room to expand their strike against car makers. But they also face risks
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
MarketBeat Week in Review – 9/18 - 9/22
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
Auto workers still have room to expand their strike against car makers. But they also face risks
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
MarketBeat Week in Review – 9/18 - 9/22
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
Auto workers still have room to expand their strike against car makers. But they also face risks
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
NASDAQ:TFFP

TFF Pharmaceuticals (TFFP) Price Target & Analyst Ratings

$0.32
-0.03 (-8.55%)
(As of 09/22/2023 ET)
Compare
Today's Range
$0.32
$0.34
50-Day Range
$0.32
$0.44
52-Week Range
$0.32
$5.15
Volume
70,206 shs
Average Volume
86,762 shs
Market Capitalization
$11.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50

TFF Pharmaceuticals Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 2 Analyst Ratings

Consensus Analyst Price Target

$5.50
1,613.40% Upside
High Prediction$7.00
Average Prediction$5.50
Low Prediction$4.00
TypeCurrent
9/23/22 to 9/23/23
1 Month Ago
8/24/22 to 8/24/23
3 Months Ago
6/25/22 to 6/25/23
1 Year Ago
9/23/21 to 9/23/22
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$5.50$5.50$5.50$18.00
Predicted Upside1,613.40% Upside656.53% Upside656.53% Upside190.17% Upside
Get TFF Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for TFFP and its competitors with MarketBeat's FREE daily newsletter.


TFFP Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TFFP Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

TFF Pharmaceuticals Stock vs. The Competition

TypeTFF PharmaceuticalsMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.66
2.49
Consensus RatingBuyModerate BuyHold
Predicted Upside1,613.40% Upside1,386.50% Upside629.68% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/25/2023HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$22.00 ➝ $4.00+575.78%
3/22/2023Jonestrading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$7.00+829.48%
(Data available from 9/23/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












TFFP Price Target - Frequently Asked Questions

What is TFF Pharmaceuticals's consensus rating and price target?

According to the issued ratings of 2 analysts in the last year, the consensus rating for TFF Pharmaceuticals stock is Buy based on the current 2 buy ratings for TFFP. The average twelve-month price prediction for TFF Pharmaceuticals is $5.50 with a high price target of $7.00 and a low price target of $4.00. Learn more on TFFP's analyst rating history.

Do Wall Street analysts like TFF Pharmaceuticals more than its competitors?

Analysts like TFF Pharmaceuticals more than other Medical companies. The consensus rating for TFF Pharmaceuticals is Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how TFFP compares to other companies.

Does TFF Pharmaceuticals's stock price have much upside?

According to analysts, TFF Pharmaceuticals's stock has a predicted upside of 656.53% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NASDAQ:TFFP) was last updated on 9/23/2023 by MarketBeat.com Staff

My Account -